Phase II study of stereotactic radiotherapy with volumetric modulated arc therapy for primary lung cancer located adjacent to organ at risk
Phase 2
- Conditions
- Primary lung cancer
- Registration Number
- JPRN-UMIN000022856
- Lead Sponsor
- Department of Radiuation Oncology, Tohoku University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
Not provided
Exclusion Criteria
1. no serious diabetes, collagen disease, cardiac disease, pulmonary disease, kidney disease and psychological disorder 2. past history or future plan of administration of molecular target drug affecting VEGF or FGF pathways 3. apparent interstitial pneumonitis or pulmonary fibrosis on CT images 4.receiving home oxygen therapy 5. Single lung 6.pregnant or lactating woman, likelihood of pregnancy 7. active infectious disease 8.implanted pacemaker or implantable cardioverter defibrillator 9. no history of thoracic radiation therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method